Comprehensive Cancer Center at University of Alabama at Birmingham
Birmingham, Alabama 35294-3410
0 studies enrolling now · 37 studies all time
What they study most
Anal Cancer, Brain and Central Nervous System Tumors, Breast Cancer, Cachexia, Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ, Endometrial Cancer, Esophageal Cancer, Extragonadal Germ Cell Tumor, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Head and Neck Cancer
Studies at this site
- AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery — Stopped early
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor — Completed
- Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer — Completed
- Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia — Completed
- Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia — Completed
- Radiofrequency Ablation in Treating Patients With Bone Metastases — Completed
- Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy — Completed
- Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer — Completed
- Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer — Completed
- Positron Emission Tomography in Determining Stage of Esophageal Cancer — Completed
- Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer — Completed
- Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer — Completed
- Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) — Completed
- Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer — Completed
- Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia — Completed
- Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia — Completed
- Combination Chemotherapy in Treating Children With Neuroblastoma — Completed
- Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia — Completed
- Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma — Completed
- Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy — Completed
- Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes — Completed
- Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia — Completed
- Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
- Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma — Completed
- Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) — Completed
- Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors — Completed
- Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma — Completed
- CA-125 in Screening Patients at High Risk for Ovarian Cancer — Withdrawn before enrolling
- Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma — Stopped early
- Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma — Completed
- Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva — Completed
- Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma — Completed
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma — Completed
- Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer — Completed
- DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors — Completed
- Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy — Withdrawn before enrolling
- Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer — Stopped early